Review: taking Promethazine and Haldol together


Summary

Drug interactions are reported among people who take Promethazine and Haldol together. This review analyzes the effectiveness and drug interactions between Promethazine and Haldol. It is created by eHealthMe based on reports of 206 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Promethazine and Haldol >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Promethazine

Promethazine has active ingredients of promethazine. It is often used in nausea. (latest outcomes from Promethazine 3,973 users)

Haldol

Haldol has active ingredients of haloperidol. It is often used in schizophrenia. (latest outcomes from Haldol 12,114 users)

On Jul, 16, 2016

206 people who take Promethazine, Haldol are studied.


Number of reports submitted per year:

Promethazine and Haldol drug interactions.

Drug effectiveness over time:

Promethazine:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 100.0% - (1 of 1 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Haldol:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 1 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Promethazine:
  • female: 100.0% - (1 of 1 people)
  • male: 0.0% - (0 of 0 people)
Haldol:
  • female: 0.0% - (0 of 1 people)
  • male: 0.0% - (0 of 0 people)

Drug effectiveness by age:

Promethazine:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 100.0% - (1 of 1 people)
  • 60+: 0.0% - (0 of 0 people)
Haldol:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 1 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

< 1 month:
  • bacteraemia
  • catheter related complication
  • haematocrit decreased
  • hyperpyrexia
  • procedural site reaction
  • road traffic accident
  • tachypnoea
  • thrombophlebitis septic
  • atrial fibrillation
  • electrocardiogram qt corrected interval prolonged
1 - 6 months:
  • confusional state
6 - 12 months:
  • confusional state
1 - 2 years:
  • diabetes mellitus
  • diabetes mellitus inadequate control
  • diabetic gastropathy
  • diabetic neuropathy
  • hypoglycaemia
2 - 5 years:
  • intervertebral disc protrusion
  • pancreatitis
  • panic attack
  • pharyngitis
  • rhinitis
  • somnolence
  • diabetes mellitus
  • aggression
  • hypersensitivity
  • insomnia
10+ years:
  • blood cholesterol increased
  • diabetes mellitus
  • hyperglycaemia
  • obesity
  • type 2 diabetes mellitus
  • visual acuity reduced
not specified:
  • dyspnoea
  • vomiting
  • anxiety
  • nausea
  • osteoarthritis
  • pain
  • diabetes mellitus
  • depression
  • pyrexia
  • impaired healing

Most common drug interactions by gender *:

female:
  • dyspnoea
  • anxiety
  • anaemia
  • depression
  • diabetes mellitus
  • spinal osteoarthritis
  • osteoarthritis
  • impaired healing
  • nausea
  • pain
male:
  • vomiting
  • agitation
  • dizziness
  • asthenia
  • nausea
  • hypotension
  • syncope
  • arthralgia
  • bronchitis
  • dyspnoea

Most common drug interactions by age *:

10-19:
  • diabetes mellitus
  • type 2 diabetes mellitus
  • obesity
20-29:
  • pyrexia
  • malaise
  • insomnia
  • cardiac arrest
  • delirium
  • diabetes mellitus
  • oliguria
  • abdominal pain upper
  • affective disorder
  • alcoholism
30-39:
  • diabetes mellitus
  • vomiting
  • hyperglycaemia
  • pain in extremity
  • type 2 diabetes mellitus
  • chest pain
  • deep vein thrombosis
  • hypertension
  • pancreatitis
  • pulmonary embolism
40-49:
  • nausea
  • vomiting
  • dyspnoea
  • urinary tract infection
  • diabetes mellitus
  • back pain
  • neck pain
  • tooth abscess
  • pyrexia
  • anaemia
50-59:
  • deep vein thrombosis
  • chest pain
  • oropharyngeal pain
  • tachypnoea
  • vomiting
  • blood creatine phosphokinase increased
  • nausea
  • psychotic disorder
  • renal failure
  • sepsis
60+:
  • anxiety
  • fall
  • osteoarthritis
  • urinary tract infection
  • constipation
  • gastrooesophageal reflux disease
  • hiatus hernia
  • vomiting
  • hypotension
  • impaired healing

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Promethazine and Haldol?

Can you answer these questions?

More questions for: Promethazine, Haldol

You may be interested in these reviews

More reviews for: Promethazine, Haldol

On eHealthMe, Promethazine (promethazine) is often used to treat nausea. Haldol (haloperidol) is often used to treat schizophrenia. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.